After less than a year in office, Srishti Gupta steps down as CEO of Swiss pharma firm Idorsia. She has also left the Board of Directors. Founder and long-standing CEO Jean-Paul Clozel will take over as interim CEO. +Get the most important news from Switzerland in your inbox Clozel remains a member of the Board of Directors at Idorsia. The Board of Directors has started the search for a new CEO, the biotech company announced on Monday. The decision was made by mutual agreement between the CEO and the Board of Directors. In a press release, Clozel thanked Gupta “for the significant contributions she has made both as CEO and as a member of the Board of Directors during an important phase in Idorsia’s development”. She has shown great commitment to Idorsia’s mission. The Board of Directors will soon propose new independent candidates for election at the Annual General Meeting on May 6, 2026. Back on road to success Gupta’s election made waves last year. The doctor had already been on …